Get more replies from employers
Send a job-specific resume in minutes.
Weil Group, Inc. seeks an Associate Quality Analyst to lead quality processes including nonconformance management, CAPA, Change Control, and Risk Management. You will monitor KPIs, drive timely action closure, and ensure investigations are rigorous with root-cause analysis.
The role requires strong bilingual English/Spanish communication and experience in pharmaceutical/biotechnological quality systems. Join a team focused on compliance and continuous improvement.
Provide leadership and direction in all aspects of quality processes that manage nonconformance and CAPA,Change Control and Risk Management.
Monitor performance through appropriate Key Performance Indicators (KPIs) for CAPA, Change Control,and Risk Management. Ensure a timely completion of actions identified in: Exception Reporting System,Change Management or Risk Management quality records and programs.
Provide leadership to ensure that actions are properly reviewed in order to ensure appropriate definition andtimely completion of actions and review of significant trends/issues to prevent regulatory liabilities andfinancial losses. Evaluate if actions were effective and verified after implementation. Confirm that actions donot adversely affect the finished product.
Maintain the required databases necessary for tracking and trending to ensure actions are implemented anddocumented.
Facilitate meetings to ensure timely identification and management of events, including but not limited to triage and CAPA review board. Drive dialogue and discussion to ensure non-conformances are appropriatelydocumented in a timely manner and that - when required - investigations are timely, rigorous and drive toroot cause to facilitate the identification and implementation of effective corrections, corrective andpreventive actions.
Provide in a timely manner information and analysis required for the Annual Quality Reviews, among othermeetings.
Review and perform statistical analysis of all exception documents by reasons (re-inspections, NCR,
Deviations and associated formal investigations). Correlate information and summarize it with the
corresponding corrective actions. Identify if there are trends indicating the need for changes manufacturing or control procedures.
**Weil Group is proud to be an Equal Employment Opportunity Employer.*